TIPE2 aggravates experimental colitis and disrupts intestinal epithelial barrier integrity by activating JAK2/STAT3/SOCS3 signal pathway.

MLA

Zeng, Lingli, et al. “TIPE2 Aggravates Experimental Colitis and Disrupts Intestinal Epithelial Barrier Integrity by Activating JAK2/STAT3/SOCS3 Signal Pathway.” Experimental Cell Research, vol. 443, no. 1, Nov. 2024, p. 114287. EBSCOhost, https://doi.org/10.1016/j.yexcr.2024.114287.

APA

Zeng, L., Wang, Y., Shen, J., Wei, X., Wu, Y., Chi, X., Zheng, X., Yu, X., Shi, Y., & Liu, W. (2024). TIPE2 aggravates experimental colitis and disrupts intestinal epithelial barrier integrity by activating JAK2/STAT3/SOCS3 signal pathway. Experimental Cell Research, 443(1), 114287. https://doi.org/10.1016/j.yexcr.2024.114287

Chicago

Zeng, Lingli, Yuping Wang, Jiaxin Shen, Xujin Wei, Yilong Wu, Xintong Chi, Xueyan Zheng, Xing Yu, Ying Shi, and Wenming Liu. 2024. “TIPE2 Aggravates Experimental Colitis and Disrupts Intestinal Epithelial Barrier Integrity by Activating JAK2/STAT3/SOCS3 Signal Pathway.” Experimental Cell Research 443 (1): 114287. doi:10.1016/j.yexcr.2024.114287.